These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26093751)

  • 21. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
    Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
    J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices.
    John R; Kamdar F; Eckman P; Colvin-Adams M; Boyle A; Shumway S; Joyce L; Liao K
    Ann Thorac Surg; 2011 Nov; 92(5):1593-9; discussion 1599-600. PubMed ID: 22051256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients.
    Teuteberg JJ; Ewald GA; Adamson RM; Lietz K; Miller LW; Tatooles AJ; Kormos RL; Sundareswaran KS; Farrar DJ; Rogers JG
    J Am Coll Cardiol; 2012 Jul; 60(1):44-51. PubMed ID: 22541834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry.
    Kirklin JK; Naftel DC; Pagani FD; Kormos RL; Myers S; Acker MA; Rogers J; Slaughter MS; Stevenson LW
    J Heart Lung Transplant; 2015 Dec; 34(12):1515-26. PubMed ID: 26681121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
    John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HeartMate 3 in Lowest INTERMACS Profile Cohort: The Swiss Experience.
    Tozzi P; Banfi C; Ahmadov K; Hullin R; Meyer P; Giraud R; Liaudet L; Gronchi F; Huber C; Kirsch M
    ASAIO J; 2017; 63(6):752-758. PubMed ID: 28557861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Gregoric ID; Bruckner BA; Jacob L; Kar B; Cohn WE; La Francesca S; Frazier OH
    Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term biventricular HeartWare ventricular assist device support--Case series of right atrial and right ventricular implantation outcomes.
    Shehab S; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Robson D; Newton PJ; Rao S; Wang L; Allida S; Connellan M; Granger E; Dhital K; Spratt P; Jansz PC; Hayward CS
    J Heart Lung Transplant; 2016 Apr; 35(4):466-73. PubMed ID: 26849954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rotary Blood Pumps as Long-Term Mechanical Circulatory Support: A Review of a 15-Year Berlin Experience.
    Hetzer R; Kaufmann MEng F; Potapov E; Krabatsch T; Delmo Walter EM
    Semin Thorac Cardiovasc Surg; 2016; 28(1):12-23. PubMed ID: 27568128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
    Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
    Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two Years of Experience in the Implantation of Heartmate III.
    Mendes V; Cerca C; Crosset M; Kirsh M
    Rev Port Cir Cardiotorac Vasc; 2017; 24(3-4):120. PubMed ID: 29701352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New circulatory support system: heartware.
    Ozbaran M; Yagdi T; Engin C; Nalbantgil S; Ayik F; Oguz E; Engin Y; Özturk P
    Transplant Proc; 2012; 44(6):1726-8. PubMed ID: 22841255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal Timing of Heart Transplant After HeartMate II Left Ventricular Assist Device Implantation.
    Steffen RJ; Blackstone EH; Smedira NG; Soltesz EG; Hoercher KJ; Thuita L; Starling RC; Mountis M; Moazami N
    Ann Thorac Surg; 2017 Nov; 104(5):1569-1576. PubMed ID: 28651783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Device exchange from HeartMate II to HeartMate 3 left ventricular assist device.
    Takeda K; Takayama H; Sanchez J; Cevasco M; Yuzefpolskaya M; Colombo PC; Naka Y
    Interact Cardiovasc Thorac Surg; 2019 Sep; 29(3):430-433. PubMed ID: 31143932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of HeartMate 3 left ventricular assist device support with a Bridge to Transplant vs a Destination Therapy strategy: a single-centre retrospective cohort.
    Kikoïne J; Nowacka A; Schukraft S; Abdurashidova T; Yerly P; Tozzi P; Ltaief Z; Rosner L; Hullin R; Kirsch M
    Swiss Med Wkly; 2024 Jul; 154():3529. PubMed ID: 39137373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes in HeartMate II Patients With No Antiplatelet Therapy: 2-Year Results From the European TRACE Study.
    Netuka I; Litzler PY; Berchtold-Herz M; Flecher E; Zimpfer D; Damme L; Sundareswaran KS; Farrar DJ; Schmitto JD;
    Ann Thorac Surg; 2017 Apr; 103(4):1262-1268. PubMed ID: 27743637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Experience With Sternotomy Versus Subcostal Approach for Exchange of HeartMate II Left Ventricular Assist Device.
    Soleimani B; Stephenson ER; Price LC; El-Banayosy A; Pae WE
    Ann Thorac Surg; 2015 Nov; 100(5):1577-80. PubMed ID: 26233277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.